{"id":"W3203371059","doi":"10.1016/j.annonc.2021.08.2108","title":"LBA2 Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase III KEYNOTE-826 study","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Chemotherapy; Internal medicine; Placebo; Oncology; Phases of clinical research; Cervical cancer; Cancer; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001398622,0.002113924,0.003947232,0.0005595453,0.0006156725,0.001215235,0.001299043,0.001880869,0.0104018],"category_scores_gemma":[0.00136516,0.001004976,0.001651297,0.0005428828,0.001289742,0.001319968,0.0004916757,0.003809058,0.001945895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008069751,"about_ca_system_score_gemma":0.001368516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001728562,"about_ca_topic_score_gemma":0.003390256,"domain_scores_codex":[0.9995677,0.0001897969,0.00002200066,0.0001011552,0.00003668397,0.00008265222],"domain_scores_gemma":[0.9992961,0.0001859996,0.0001396971,0.00005847259,0.00005032942,0.000269381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9746385,0.008504315,0.0001703368,0.0007382873,0.0006633594,0.00002084971,0.00003547248,0.0002423935,0.003097673,0.00009925674,0.0007690699,0.01102057],"study_design_scores_gemma":[0.9485155,0.04947552,0.0006055699,0.00002650426,0.0003090009,0.00001397966,0.00001509888,0.0002405726,0.0002706525,0.0000823119,0.00043415,0.00001098158],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762174,0.006687761,0.001204227,0.0009789017,0.001188964,0.006955979,0.002300982,0.0003053649,0.004160421],"genre_scores_gemma":[0.966853,0.005365161,0.002634624,0.001924485,0.0008945939,0.008746244,0.001659878,0.00006945633,0.01185256],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0104018,"threshold_uncertainty_score":0.03479755,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2111608759072992,"score_gpt":0.4722033107881647,"score_spread":0.2610424348808655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}